PMN

ProMIS Neurosciences, Inc. (PMN) Economic Moat Analysis (2026)

Invetso Score: 5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Intangible Assets

Score: 7.5 (Strong)

ProMIS’s intangible assets are anchored by its proprietary EpiSelect™ platform, regulatory recognition, and targeted IP, which collectively provide a strong foundation for competitive differentiation. The durability of these advantages depends on successful clinical outcomes and ongoing IP protection.

Network Effects

Score:

Network effects are not a primary moat source for ProMIS at this stage. Any future ecosystem value will depend on successful clinical development and strategic partnerships, which are not yet established.

Switching Costs

Score:

Switching costs are not material at present but could become moderate if ProMIS’s therapies prove superior and are integrated into standard of care. This factor is not a current moat driver.

Cost Advantage

Score:

ProMIS does not currently possess a cost advantage. Any future efficiency gains from its platform remain unproven and are not a material moat factor at this stage.

Efficient Scale

Score:

While ProMIS operates in markets with high entry barriers, it does not yet possess efficient scale advantages. Future entrenchment will depend on successful commercialization and market adoption.

Overall Score

Score:

ProMIS Neurosciences demonstrates strong intangible asset potential through its proprietary platform, regulatory recognition, and focused IP. However, the absence of approved products, commercial scale, and network effects limits the durability and breadth of its moat. The company’s competitive position is contingent on clinical success and future commercialization. At present, ProMIS’s moat is moderate and primarily driven by intangible assets, with other factors providing limited support.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on ProMIS Neurosciences, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →